user

Population Pharmacokinetic Model and Bayesian Estimator for Mycophenolate Mofetil (MMF) in Lung Transplantation

被引：0
|
作者：
Marquet, P. [1 ]
de Winter, B. C. M. [1 ]
Monchaud, C. [1 ]
Premaud, A. [1 ]
Pison, C. [2 ]
Kessler, R. [3 ]
Reynaud-Gaubert, M. [4 ]
Dromer, C. [5 ]
Stern, M. [6 ]
Guillemain, R. [7 ]
Knoop, C. [8 ]
Estenne, M. [8 ]
Rousseau, A. [1 ]
机构：
[1] Univ Limoges, CHU Limoges, INSERM, UMR S850, F-87065 Limoges, France
[2] CHU Grenoble, Serv Med Aigue Specialisee, Grenoble, France
[3] Nouvel Hop Civil, Serv Pneumol, Strasbourg, France
[4] CHU Nord, Serv Chirurg Thorac, Marseille, France
[5] Hop Haut Leveque, Serv Chirurg Thorac, Bordeaux, France
[6] Hop Foch, Serv Pneumol, Suresnes, France
[7] AP HP, HEGP, Serv Chirurg Cardiovasc, Paris, France
[8] Free Univ Brussels, Hop Erasme, Serv Pneumol, B-1070 Brussels, Belgium
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1320
引用
收藏
页码：415 / 415
页数：1
相关论文
共 50 条
  • [31] Development of a population model and a bayesian estimator for Envarsus® in liver transplantation
    Woillard, J. B.
    Debord, J.
    Monchaud, C.
    Saint-Marcoux, F.
    Marquet, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 42 - 42
  • [32] MYCOPHENOLATE MOFETIL (MMF) IN PEDIATRIC (PED) RENAL-TRANSPLANTATION (TX) - A REPORT OF THE PED MMF STUDY-GROUP
    ETTENGER, R
    WARSHAW, B
    MENTSER, M
    POTTER, D
    COHEN, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1082 - 1082
  • [33] Cyclosporine A (CSA) vs. tacrolimus (TAC), in combination with mycophenolate mofetil (MMF) and steroids as primary immunosuppression after lung transplantation
    Zuckermann, A
    Reichenspurner, H
    Klepetko, W
    Meiser, B
    Birsan, T
    Treede, H
    Kupilik, N
    Wisser, W
    TRANSPLANTATION, 1999, 67 (07) : S236 - S236
  • [34] Pharmacokinetic modelling and development of Bayesian estimators for the therapeutic drug monitoring of Mycophenolate mofetil in non myeloablative haematopoietic cell transplantation
    Saini-Marcoux, F.
    Royer, B.
    Debord, J.
    Larosa, F.
    Legrand, F.
    Deconinck, E.
    Marquet, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 22 - 22
  • [35] Mycophenolate mofetil (MMF) versus azathioprine (AZA) in pancreas transplantation: a single-center experience
    Rigotti, P
    Cadrobbi, R
    Baldan, N
    Sarzo, G
    Parise, P
    Furian, L
    Marchini, F
    Ancona, E
    CLINICAL NEPHROLOGY, 2000, 53 (04) : B52 - B54
  • [36] Use of Mycophenolate Mofetil (MMF) in renal transplantation. Results of a single-centre trial
    Pastural, M
    Barrou, B
    Golmard, JL
    Gorichon-Radideau, E
    Manighetti, J
    Ourahma, S
    Benalia, H
    Mouquet, C
    Chatelain, C
    Bitker, MO
    PROGRES EN UROLOGIE, 1999, 9 (01): : 19 - 25
  • [37] Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation
    Whyte, RI
    Rossi, SJ
    Mulligan, MS
    Florn, R
    Baker, L
    Gupta, S
    Martinez, FJ
    Lynch, JP
    ANNALS OF THORACIC SURGERY, 1997, 64 (04): : 945 - 948
  • [38] Preliminary experience with mycophenolate mofetil used after lung transplantation
    O'Hair, DP
    Cantu, E
    McGregor, C
    Jorgensen, B
    Gerow-Smith, R
    Galantowicz, ME
    Schulman, LL
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1998, 17 (09): : 864 - 868
  • [39] Population pharmacokinetics and Bayesian estimation of mycophenolate mofetil in patients with autoimmune hepatitis
    Nanga, Tom M.
    Woillard, Jean-Baptiste
    Rousseau, Annick
    Marquet, Pierre
    Premaud, Aurelie
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (11) : 4732 - 4741
  • [40] Prevalence of bronchiolitis obliterans syndrome (BOS) in lung transplant recipients treated with mycophenolate mofetil (MMF).
    Birsan, T
    Zuckermann, A
    Deviatko, E
    Taghavi, S
    Dekan, G
    Klepetko, W
    TRANSPLANTATION, 1999, 67 (07) : S111 - S111
12345